-
Kenya's economy faces climate change risks: World Bank
-
US-Iran deal met with hope, scepticism in Mideast
-
German working-age population to shrink dramatically: study
-
'For sure': Macron to preach stronger Europe vision at G7 swansong
-
Crude prices plunge, stocks surge on US-Iran peace deal
-
Starbucks Korea to shutter outlets for history lessons after 'Tank Day' fiasco
-
Courts cracking down on error-strewn AI-assisted legal briefs
-
Bitter communion: Cuban priests ordered to ration mass wafers
-
In crisis-hit Cuba, World Cup offers brief respite
-
UK intercepts Russian shadow fleet vessel in Channel
-
London, Tokyo agree $24-bn investment deal
-
Indonesian economy comes up for air but struggles to win back investors
-
Trump says US-Iran deal to be signed Sunday, Hormuz to open after
-
Between Trump and a hard place: Fed chair Warsh to lead first rate meeting
-
High-school drop out to big time crime boss, Venezuela's 'Nino Guerrero'
-
US-Iran deal could be finalised soon, mediator Pakistan says
-
Thousands gather in Thai capital to mourn late princess
-
US says downed multiple Iran drones as both insist deal closer
-
SpaceX: Five key moments, from first launch to Starship megarocket
-
US clears Paramount's $111 bn Warner Bros. takeover
-
Iran and US say deal closer than ever
-
Cuba opens more sectors to private business
-
World Cup struggles to ignite US excitement
-
US appellate court upholds Sam Bankman-Fried criminal sentence
-
France bids farewell to girl, 11, whose killing sparked outrage
-
Wall Street wobbles as SpaceX shares launch, oil slides on Mideast deal hopes
-
SpaceX lifts off in record Wall Street debut
-
US deportation flight carrying Iranians en route to C.African Republic
-
At a Libyan university once ravaged by war, students dream again
-
Kenya mourns schoolgirls killed in suspected dorm arson attack
-
Stocks rally, oil slides on Mideast deal hopes
-
'All of us of are migrants,' pope says in Canary Islands
-
Switzerland split on immigration vote: four perspectives
-
Thai princess dies aged 47 after three years in hospital
-
Science fiction? Musk's lofty SpaceX goals unrealistic, skeptics say
-
Asia stocks up, oil down on Mideast deal hopes
-
From cage fights to the White House, UFC marches into mainstream
-
Pope ends Spain visit with migrant meetings
-
Ex-Tottenham owner sells art collection in blockbuster auction
-
Antarctic Peninsula sees record high June temperatures
-
US stocks rally, oil prices fall as Trump calls off fresh Iran strikes
-
SpaceX to make historic IPO that could make Musk a trillionaire
-
El Nino is back, but its effects vary widely
-
First leather bag from T-Rex cells to be auctioned in Paris
-
Four times as many icebergs calved from Greenland glaciers: study
-
Stocks rebound, oil wavers as traders weigh Iran, rates outlook
-
Niger criminalises same-sex relations with jail terms
-
Smuggled dinosaur fossils return to Mongolia after two decades
-
Over 260 Nigerians fleeing xenophobic attacks in S. Africa return home
-
Pope condemns 'indifference' towards migrants on Canaries trip
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
P.Petrenko--CPN